Streetbeat News

Regulatory

ENSV

Enservco is working closely with NYSE American through a formal appeals process to maintain its listing. During this period, Enservco's stock will continue to be listed and traded on the NYSE American exchange.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 9:10 pm

BMY

Bristol Myers Squibb announced that the FDA has granted accelerated approval to Augtyro (Repotrectinib) for patients with NTRK-positive locally advanced or metastatic solid tumors.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 8:48 pm

ATIF

Atif Holdings Ltd has filed a prospectus with the SEC for the offering and resale of an aggregate of 2.3 million ordinary shares by selling stockholders.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 8:24 pm

RUM

Rumble Inc. (NASDAQ:RUM) has sent a letter to the CEO of the London Stock Exchange Group (LSEG) regarding errors in the determination of the Russell 3000 Index, which could lead to Rumble's exclusion. Despite repeated requests, LSEG has not corrected the errors in their calculations of Rumble's voting rights.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 8:21 pm

ACAB

Atlantic Coastal Acquisition Corp. II (ACAB) has received a deficiency notification from Nasdaq, indicating that the company is not in compliance with the exchange's listing requirements.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 8:17 pm

BURU

NYSE American has announced that it will begin delisting proceedings against Nuburu, with trading to be suspended immediately.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 8:17 pm

VXRT

Vaxart has received up to $453 million from BARDA for a Phase 2b study of its oral COVID-19 vaccine. The initial $65.7 million will fund the study start-up, with the remaining $387.2 million contingent on further study approval. Enrollment is expected to begin in summer 2024, with interim analysis by Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 8:16 pm

TFX

The FDA has classified the recall of Teleflex/Arrow International's Arrow FiberOptix and UltraFLEX Intra-Aortic Balloon Catheter Kits as a Class I recall due to a manufacturing issue. This issue has been potentially linked to 31 injuries and 3 deaths.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 7:46 pm

IGC

LFSWD

Anson Funds settled with the SEC for $2.25 million over a secret relationship with a short seller that affected two cannabis companies, Lifeist Wellness Inc. (OTC:LFSWD) and IGC Pharma Inc. (NYSE:IGC). The scheme involved short positions and negative reports to profit from stock price drops.

Portfolio Pulse from Rolando García

June 13, 2024 | 7:29 pm

SNGX

Soligenix has filed a new patent application for 'Compositions And Methods Of Manufacturing Trivalent Filovirus Vaccines'.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2024 | 7:16 pm